Literature DB >> 15114003

Working safely with vaccinia virus: laboratory technique and the role of vaccinia vaccination.

Stuart N Isaacs1.   

Abstract

Vaccinia virus, the prototype Orthopoxvirus, is widely used in the laboratory as a model system to study various aspects of viral biology, virus-host interactions, and as a protein expression system and a vaccine vector. The ubiquitous use of vaccinia viruses in the laboratory raises certain safety concerns, because the virus can be a pathogen in individuals with immunological and dermatological abnormalities and, on occasion, can cause serious problems in normal hosts. This chapter reviews standard operating procedures when working with vaccinia virus and issues surrounding the use of prophylactic smallpox vaccination for laboratory workers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114003     DOI: 10.1385/1-59259-789-0:001

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.

Authors:  Tjeerd G Kimman; Eric Smit; Michèl R Klein
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

2.  Vaccinia virus entry, exit, and interaction with differentiated human airway epithelia.

Authors:  Paola D Vermeer; Julia McHugh; Tatiana Rokhlina; Daniel W Vermeer; Joseph Zabner; Michael J Welsh
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

3.  Ocular vaccinia infection in laboratory worker, Philadelphia, 2004.

Authors:  Felicia M T Lewis; Esther Chernak; Erinn Goldman; Yu Li; Kevin Karem; Inger K Damon; Richard Henkel; E Claire Newbern; Patrina Ross; Caroline C Johnson
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

4.  Genomic identification of human vaccinia virus keratoconjunctivitis and its importance as a laboratory-acquired infection.

Authors:  Zahra Movahedi Motlagh; Azam Mokhtari; Mohammadreza Mahzounieh
Journal:  Indian J Ophthalmol       Date:  2016-11       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.